Valsartan with Enalaprilat in Elderly Hypertensive Patients the Effect of Ventricular Arrhythmias

ZHAO De-cheng; YUAN Jian-xi

Abstract：Objective:To comparative valsartan and enalaprilat ventricular arrhythmias in patients with senile hypertension. Method:Selection in the author’s hospital from January 2011 to October 2013 treated 100 cases of elderly patients with hypertension with ventricular arrhythmia,according to random number table method was divided into treatment group and control group,50 cases each,two groups of patients treated with valsartan and enalaprilat respectively, compared two drugs on blood pressure in elderly patients with hypertension combined ventricular arrhythmia and ventricular arrhythmia occurrence.Result:After treatment,two groups of patients with systolic and diastolic blood pressure were significantly lower than before treatment,and the difference was statistically significant (P<0.05). But systolic pressure,diastolic pressure between the two groups after treatment had no statistical significance (P>0.05). The treatment group after treatment was significantly reduced the occurrence of ventricular arrhythmia times,compared with the control group after treatment also significantly reduced, the difference was statistically significant (P<0.05). Ventricular arrhythmias in patients with two groups of reduce the related factors of the correlation analysis, the control group of patients with ventricular arrhythmia less and systolic pressure,diastolic pressure drops,and left ventricular myocardium closely related to the quality index was lower;ventricular arrhythmia treatment group reduced with systolic pressure,diastolic blood pressure decreased and the left ventricular myocardial quality index decrease no correlation.Conclusion:The use of valsartan treatment in elderly patients with hypertension and ventricular arrhythmia,not only can effectively control the blood pressure,and can effectively reduce the occurrence of ventricular arrhythmia,less adverse reactions,patients are easy to accept,worthy of clinical popularization and application.